DR. CARLTON D. DONALD

FOUNDER, PRESIDENT & CEO

Dr. Donald founded PHIGENIX, Inc. Pharmaceutical and Biomedical Research Company in 2007, and is the inventor of the intellectual property around which the company is based.  Prior to joining PHIGENIX, Dr. Donald was a professor at the Medical University of South Carolina and has over 25 years of experience as cancer biologist.  He has published a number of ground-breaking, peer-reviewed articles, has over 36 abstracts and has received national and international recognition for his work. Dr. Donald received his BS degree in biology from Florida A&M University, his M.S. and Ph.D. in Molecular Biology from Clark Atlanta University and completed two postdoctoral fellowships at Emory University including one in molecular urologic therapeutics. 

 
WD+Bodyshot+copy.jpg

Mrs. Wennifer H. Donald, VICE-PRESIDENT, COO

Mrs. Donald has over 20 years of experience in business management. She has served as an corporate executive at the national headquarters of a Fortune 500 financial institution in Atlanta, Georgia.  In addition, she has also served as lead operations manager for a multi-million dollar firm located in Atlanta, Georgia.

 
JB.png

Dr. J. PAGE Brown, Head of Research and Development

Dr. Brown is a pharmaceutical veteran with substantial experience in product development and project management including serving as a lead scientist and biochemist for Procter and Gamble.

West+Headshot+2.jpg

Dr. Charles A. West, Head of Business Development

Dr. West is a catalyst for economic optimization.  He leveraged myriad educational, training, business consulting and research experiences into successful entrepreneurial and non profit endeavors. Dr. West has served as Senior Consultant and Chief Operating Officer for a Kauffman Foundation spinoff and Founding Director of ThinkShift, Inc. , now The DeBruce Foundation.

Scott%2BHeadshot%2Bcopy.jpg

Mr. scott cha-choe, director

Mr. Cha-Choe is currently EVP & COO for an Atlanta-based investment consulting firm advising institutional clients-pension funds, foundations and endowments.  He has served on various boards and has been on advisory roles with startup companies utilizing his experience in strategic planning and business development.